Tryptase is associated with sensitization, FeNO, and allergic morbidity
in teenagers from the PARIS birth cohort
Abstract
Background: Basal serum tryptase (bST) is the main marker of
the mast cell compartment. In spite of the importance of mast cells
regarding allergic manifestations, the relationship between bST and
allergy-related outcomes has been seldomly described, particularly
during early life. In addition, circulating tryptase concentrations
depend of mast cell load, genetic determinants, and several
physiological, pathological, and exposure factors. This study aimed to
assess the potential association between bST and allergy-related
outcomes in teenagers from a birth cohort. Methods: This
cross-sectional study included 610 teenagers at 15/16 years
participating to a French ongoing population-based prospective birth
cohort. Participants answered to self-administered questionnaires,
received a health check-up and blood sampling. Considered
allergy-related outcomes consisted of sensitization by skin prick test
and specific IgE measurements, fraction of exhaled NO measurements, and
standardized diagnosis of allergy-related morbidities. Results:
At 15 years , higher bST was associated with higher prevalence
of sensitization to inhalants and foods. Furthermore, bST was positively
associated with intermediate-to-high FeNO levels, even after adjustments
for covariates including sensitization and eosinophils. After
controlling for potential confounders, higher bST was also associated to
higher risk of displaying any hypersensitivity reactions, reactions to
drugs, and to asthma with associated sensitization. Furthermore, higher
bST was associated with poorer control scores among
sensitization-associated asthma. Conversely, higher bST was associated
with lower risk of presenting dermatitis without associated
sensitization. Conclusion: In teenagers from a birth cohort,
higher bST was associated with more frequent sensitization,
intermediate-to-high FeNO values, and allergy-related morbidities,
including asthma.